Advanced search
Publication Cover
Leukemia & Lymphoma Volume 51, 2010 - Issue 1
Submit an article Journal homepage
291
Views
6
CrossRef citations to date
0
Altmetric
Letters to the Editor

Weekly treatment with a combination of bortezomib and bendamustine in relapsed or refractory indolent non-Hodgkin lymphoma

Peter MoosmannCenter of Oncology, Hematology, and Transfusion Medicine, Kantonsspital Aarau, Aarau, SwitzerlandCorrespondence[email protected]
,
Marc HeizmannCenter of Oncology, Hematology, and Transfusion Medicine, Kantonsspital Aarau, Aarau, Switzerland
,
Nina KotrubczikCenter of Oncology, Hematology, and Transfusion Medicine, Kantonsspital Aarau, Aarau, Switzerland
,
Martin WernliCenter of Oncology, Hematology, and Transfusion Medicine, Kantonsspital Aarau, Aarau, Switzerland
&
Mario BargetziCenter of Oncology, Hematology, and Transfusion Medicine, Kantonsspital Aarau, Aarau, Switzerland
Pages 149-152 | Received 24 Apr 2009, Accepted 21 Aug 2009, Published online: 01 Oct 2009

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Kuniaki Itoh, Tadahiko Igarashi, Hiroyuki Irisawa, Nobuyuki Aotsuka, Shinichi Masuda, Yoshikazu Utsu, Hideki Tsujimura, Kunihiro Tsukasaki & Hisashi Wakita. (2018) Randomized phase II study of a bendamustine monotherapy schedule for relapsed or refractory low-grade B-cell non-Hodgkin lymphoma or mantle cell lymphoma (RABBIT-14). Leukemia & Lymphoma 59:7, pages 1606-1613.
Read now
Marco Montillo, Francesca Ricci, Alessandra Tedeschi, Eleonora Vismara & Enrica Morra. (2010) Bendamustine: new perspective for an old drug in lymphoproliferative disorders. Expert Review of Hematology 3:2, pages 131-148.
Read now

Articles from other publishers (4)

Liat Vidal, Anat Gafter-Gvili, Ronit Gurion, Pia Raanani, Martin Dreyling & Ofer Shpilberg. (2012) Bendamustine for patients with indolent B cell lymphoid malignancies including chronic lymphocytic leukaemia. Cochrane Database of Systematic Reviews.
Crossref
Jonathan W. FriedbergJulie M. VoseJennifer L. KellyFaith YoungSteven H. BernsteinDerick PetersonLynn RichSusan BlumelNicole K. ProiaJane LiesveldRichard I. FisherJames O. ArmitageSteven Grant & John P. Leonard. (2011) The combination of bendamustine, bortezomib, and rituximab for patients with relapsed/refractory indolent and mantle cell non-Hodgkin lymphoma. Blood 117:10, pages 2807-2812.
Crossref
Karly P. Garnock-Jones. (2010) Bendamustine. Drugs 70:13, pages 1703-1718.
Crossref
Nishant Tageja & Jasdeepa Nagi. (2010) Bendamustine: something old, something new. Cancer Chemotherapy and Pharmacology 66:3, pages 413-423.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.